Exploring the Association of Burning Mouth Syndrome with Depressive and Anxiety Disorders in Middle-Aged and Older Adults: A Systematic Review.
anxiety
burning mouth syndrome
depression
middle age
older people
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
19 Jun 2023
19 Jun 2023
Historique:
received:
27
04
2023
revised:
15
06
2023
accepted:
15
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Burning Mouth Syndrome (BMS) is an idiopathic condition mainly affecting middle-aged and older individuals with hormonal disturbances or psychiatric disorders and is characterized by chronic pain. The etiopathogenesis of this multifactorial syndrome is largely unknown. The objective of the present systematic review was therefore to evaluate the relationship of BMS with depressive and anxiety disorders in middle-aged and older individuals. We selected studies evaluating BMS and depressive and anxiety disorders assessed with validated tools, published from their inception up to April 2023, using PubMed, MEDLINE, EMBASE, Scopus, Ovid, and Google Scholar databases and adhering to the PRISMA 2020 guidelines/PRISMA 2020 27-item checklist. This study is registered on PROSPERO (CRD42023409595). The National Institutes of Health Quality Assessment Toolkits for Observational Cohort and Cross-Sectional Studies were used to examine the risk of bias. Two independent investigators rated 4322 records against the primary endpoint and found 7 records meeting the eligibility requirements. Anxiety disorders were found to be the most common psychiatric disorders related to BMS (63.7%), followed by depressive disorders (36.3%). We found a moderate association of BMS with anxiety disorders, with multiple studies included ( In middle-aged and older subjects, anxiety and depressive disorders may be potentially related to the development of BMS. Furthermore, also in these age groups, females showed higher risk of developing BMS than males, even when taking into account multimorbidity such as sleep disorders, personality traits, and biopsychosocial changes as suggested by study-specific findings.
Sections du résumé
BACKGROUND
BACKGROUND
Burning Mouth Syndrome (BMS) is an idiopathic condition mainly affecting middle-aged and older individuals with hormonal disturbances or psychiatric disorders and is characterized by chronic pain. The etiopathogenesis of this multifactorial syndrome is largely unknown. The objective of the present systematic review was therefore to evaluate the relationship of BMS with depressive and anxiety disorders in middle-aged and older individuals.
METHODS
METHODS
We selected studies evaluating BMS and depressive and anxiety disorders assessed with validated tools, published from their inception up to April 2023, using PubMed, MEDLINE, EMBASE, Scopus, Ovid, and Google Scholar databases and adhering to the PRISMA 2020 guidelines/PRISMA 2020 27-item checklist. This study is registered on PROSPERO (CRD42023409595). The National Institutes of Health Quality Assessment Toolkits for Observational Cohort and Cross-Sectional Studies were used to examine the risk of bias.
RESULTS
RESULTS
Two independent investigators rated 4322 records against the primary endpoint and found 7 records meeting the eligibility requirements. Anxiety disorders were found to be the most common psychiatric disorders related to BMS (63.7%), followed by depressive disorders (36.3%). We found a moderate association of BMS with anxiety disorders, with multiple studies included (
CONCLUSIONS
CONCLUSIONS
In middle-aged and older subjects, anxiety and depressive disorders may be potentially related to the development of BMS. Furthermore, also in these age groups, females showed higher risk of developing BMS than males, even when taking into account multimorbidity such as sleep disorders, personality traits, and biopsychosocial changes as suggested by study-specific findings.
Identifiants
pubmed: 37374003
pii: jpm13061014
doi: 10.3390/jpm13061014
pmc: PMC10305447
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Aust Dent J. 2005 Dec;50(4):220-3; quiz 288
pubmed: 17016885
Biomolecules. 2021 Aug 18;11(8):
pubmed: 34439903
Mov Disord. 1996 Jul;11(4):421-6
pubmed: 8813222
Cephalalgia. 2020 Feb;40(2):129-221
pubmed: 32103673
J Headache Pain. 2012 Apr;13(3):255-7
pubmed: 22322657
J Pers Disord. 2005 Feb;19(1):84-93
pubmed: 15899722
Cephalalgia. 2017 Mar;37(3):265-277
pubmed: 27121358
Clin Psychol Rev. 2004 Mar;24(1):75-98
pubmed: 14992807
Dent Med Probl. 2020 Jul-Sep;57(3):295-304
pubmed: 33113291
J Pers Med. 2022 Oct 28;12(11):
pubmed: 36579500
Maturitas. 2007 Sep 20;58(1):102-6
pubmed: 17601690
JAMA Otolaryngol Head Neck Surg. 2020 Jun 1;146(6):561-569
pubmed: 32352482
J Psychosom Res. 2015 May;78(5):495-498
pubmed: 25796514
World J Gastroenterol. 2013 Feb 7;19(5):665-72
pubmed: 23429751
Pain. 2017 Mar;158(3):369-370
pubmed: 28135214
J Psychosom Res. 2012 Feb;72(2):142-6
pubmed: 22281456
Headache. 2012 Jun;52(6):1019-25
pubmed: 22607629
Int J Environ Res Public Health. 2023 Feb 15;20(4):
pubmed: 36834086
Medicine (Baltimore). 2023 Jan 20;102(3):e32648
pubmed: 36701734
J Oral Pathol Med. 2006 Sep;35(8):466-71
pubmed: 16918597
Crit Rev Oral Biol Med. 2003;14(4):275-91
pubmed: 12907696
Dermatol Clin. 1996 Apr;14(2):339-54
pubmed: 8725589
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Oral Sci. 2015;57(4):355-60
pubmed: 26666859
Int J Dermatol. 2003 Jun;42(6):491-5
pubmed: 12786883
J Oral Rehabil. 2020 Jun;47(6):713-719
pubmed: 32196724
Scand J Pain. 2020 Oct 28;21(1):183-190
pubmed: 33108343
J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1285-90
pubmed: 25351854
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Apr;105(4):460-5
pubmed: 18329582
J Dent Res Dent Clin Dent Prospects. 2010 Spring;4(2):37-41
pubmed: 22991594
Acta Odontol Scand. 2016;74(2):155-60
pubmed: 26494262
Oral Dis. 2022 Sep;28(6):1431-1440
pubmed: 33818878
Minerva Stomatol. 2005 Sep;54(9):489-96
pubmed: 16215533